References
- Schoorl M, Schoorl M, Nube MJ, Bartels PC. Platelet depletion, platelet activation and coagulation during treatment with hemodialysis. Scand J Clin Lab Invest 2011;71:240–7.
- Gritters M, Borgdorff P, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Tangelder GJ, Nube MJ. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility? Nephrol Dial Transplant 2008;23:2911–17.
- Matzdorff AC, Kemkes-Matthes B, Voss R, Pralle H. Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis 1996;26:98–106.
- de Boer AC, Genton E, Turpie AG. Chemistry, measurement, and clinical significance of platelet specific proteins. Crit Rev Clin Lab Sci 1982;18:183–211.
- Sagedal S, Hartmann A, Sundstrom K, Bjornsen S, Brosstad F. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant 2001;16:987–93.
- Gritters-van den Oever M, Schoorl M, Schoorl M, Bartels PC, Grooteman MP, Nube MJ. The role of the extracorporeal circuit in the trapping and degranulation of platelets. Blood Purif 2009;28:253–9.
- Daugirdas JT, Bernardo AA. Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia. Kidney Int 2012;82:147–57.
- Sagedal S, Witczak BJ, Osnes K, Hartmann A, Os I, Eikvar L, Klingenberg O, Brosstad FA. heparin-coated dialysis filter (AN69 ST) does not reduce clotting during hemodialysis when compared to a conventional polysulfone filter (Fx8). Blood Purif 2011;32:151–5.
- Kessler M, Gangemi C, Gutierrez Martones A, Lacombe JL, Krier-Coudert MJ, Galland R, Kielstein JT, Moureau F, Loughraieb N. Heparin-grafted dialysis membrane allows minimal systemic anticoagulation in regular hemodialysis patients: a prospective proof-of-concept study. Hemodial Int 2013;17:282–93.
- Laville M, Dorval M, Fort Ros J, Fay R, Cridlig J, Nortier JL, Juillard L, Debska-Slizien A, Fernandez Lorente L, Thibaudin D, Franssen C, Schulz M, Moureau F, Loughraieb N, Rossignol P. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis. Kidney Int 2014;86:1260–7.
- Sagripanti A, Carpi A, Baicchi U, Morganti M, Rosaia B, Nicolini A, Mittermayer C. Plasmatic parameters of coagulation activation in thrombotic microangiopathy. Biomed Pharmacother 1996;50:357–62.
- Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4:1205–13.
- Kandrotas RJ. Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992;22:359–74.
- Bratt G, Tornebohm E, Widlund L, Lockner D. Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers. Thromb Res 1986;42:613–20.
- Sagedal S, Hartmann A, Sundstrom K, Bjornsen S, Fauchald P, Brosstad F. A single dose of dalteparin effectively prevents clotting during haemodialysis. Nephrol Dial Transplant 1999;14:1943–7.
- Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M, Oystese R. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. Eur J Cardiothorac Surg 1996;10:449–55.
- Gritters-van den Oever M, Grooteman MP, Bartels PC, Blankestijn PJ, Bots ML, van den Dorpel MA, Schoorl M, Schoorl M, Ter Wee PM, Nube MJ. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST. Nephrol Dial Transplant 2009;24:3461–8.
- Krummel T, Scheidt E, Borni-Duval C, Bazin D, Lefebvre F, Nguyen P, Hannedouche T. Haemodialysis in patients treated with oral anticoagulant: should we heparinize? Nephrol Dial Transplant 2014;29:906–13.
- Stegmayr CJ, Jonsson P, Forsberg U, Stegmayr BG. Development of air micro bubbles in the venous outlet line: an in vitro analysis of various air traps used for hemodialysis. Artif Organs 2007;31:483–8.